The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Its solution was to refile the drug under a different brand name and now, a year later, odevixibat has a second positive opinion from the CHMP for ALGS under the new Kayfanda brand. Its orphan ...